BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0740
0.00 (0.00%)
Jun 4, 2026, 2:45 PM AEST
Hatton National Bank Market Cap
BCAL Diagnostics has a market cap or net worth of 27.28 million as of June 5, 2026. Its market cap has decreased by -20.69% in one year.
Market Cap
27.28M
Enterprise Value
27.39M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 27.28M, a decrease of -47.25%. That is a compound annual growth rate of -12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 27.28M | -29.41% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 384.10M |
| Monash IVF Group | 270.80M |
| Healius | 235.99M |
| Cryosite | 51.74M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 38.36M |
| Rhythm Biosciences | 37.16M |
| ImExHS | 18.92M |